Evidence map›Paper›PMID 30760002›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus.

Asmaa M Zahran, Ismail L Mohamed, Osama M El Asheer, Deiaaeldin M Tamer, Mohamed G M Abo-ELela, Mona H Abdel-Rahim, Omnia H B El-Badawy, Khalid I Elsayh

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Vascularization in tissue engineering: fundamentals and state-of-art.Progress in biomedical engineering (Bristol, England) · 2020
    Article
  10. Annexin VJournal of diabetes research · 2020
    Article
  11. Coagulatory Defects in Type-1 and Type-2 Diabetes.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Asmaa M Zahran1 Department of Clinical Pathology, South Egypt Cancer Institute, Assiut, Egypt.
Ismail L Mohamed2 Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Osama M El Asheer2 Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Deiaaeldin M Tamer2 Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Mohamed G M Abo-ELela2 Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Mona H Abdel-Rahim3 Medical Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Omnia H B El-Badawy3 Medical Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Khalid I Elsayh2 Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Assiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aim: Hyperglycemia in type 1 diabetes (T1D) is accompanied by endothelial cell dysfunction which is known to contribute to the pathogenesis of cardiovascular disorders. The aim of the current study was to explore the profile of circulating endothelial progenitor cells (EPCs), circulating endothelial cells (CECs), endothelial and platelet derived micropaticles (EMPs, PMPs) and total microparticles (TMPs), in T1D children in relation to each other and to the metabolic disorders accompanying T1D. PATIENTS AND

methods: Thirty T1D patients and 20 age and sex matched healthy volunteers were assessed for HbA1c level and lipid profile. Quantification of CECs, EPCs, TMPs, EMPs and PMPs was done by flow cytometry.

results: The mean levels of EMPs, PMPs, TMPs and CECs were significantly higher in diabetic children compared to controls. Meanwhile, the levels of EPCs were significantly lower in diabetic children compared to controls. Both PMPs and CECs showed the highest significant differences between patients and controls and their levels were directly related to HbA1c, total cholesterol, LDL and triglycerides. A moderate correlation was observed between the frequency of PMPs and CECs. EPCs revealed negative correlations with both LDL and triglycerides. TMPs were only related to LDL, while EMPs were only related to HbA1c.

conclusion: Although there is disturbance in the levels of EMPs, PMPs, TMPs, CECs and EPCs in type 1 diabetic children compared to the controls, only the levels of PMPs and CECs were closely affected by the poor glycemic control and dyslipidemia occurring in T1D; thus may contribute to a higher risk of cardiovascular diseases.

Indexed as

Cell-Derived MicroparticlesChildDiabetes Mellitus, Type 1Endothelial Progenitor CellsEndothelium, VascularFemaleFlow CytometryHumansMaleCECsEMPsEPCsmicroparticlesPMPsT1D

Identifiers

PMID30760002
PMCPMC6714921
OpenAlexW2914121733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.